Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,457 | 335 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,037 | 71 | $0 (2024) |
| Novo Nordisk Inc | $711.13 | 47 | $0 (2024) |
| Amgen Inc. | $645.57 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $351.12 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $285.73 | 23 | $0 (2024) |
| PFIZER INC. | $200.13 | 14 | $0 (2024) |
| Lilly USA, LLC | $169.71 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $137.94 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $135.08 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $123.28 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 57 | ABBVIE INC. ($174.67) |
| 2023 | $686.40 | 37 | Novo Nordisk Inc ($173.37) |
| 2022 | $532.24 | 31 | Novo Nordisk Inc ($132.66) |
| 2021 | $1,234 | 86 | AbbVie Inc. ($313.33) |
| 2020 | $414.64 | 28 | Amgen Inc. ($69.66) |
| 2019 | $368.26 | 24 | AbbVie, Inc. ($88.32) |
| 2018 | $447.51 | 32 | Amgen Inc. ($136.10) |
| 2017 | $746.33 | 40 | AbbVie, Inc. ($225.64) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: VACCINE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neurology | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,039 | 1,263 | $232,639 | $58,105 |
| 2022 | 14 | 982 | 1,199 | $199,237 | $54,508 |
| 2021 | 15 | 1,078 | 1,264 | $186,435 | $53,858 |
| 2020 | 12 | 1,003 | 1,356 | $194,242 | $50,281 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 247 | $95,564 | $20,507 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $45,985 | $15,296 | 33.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 50 | 175 | $31,601 | $8,166 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 63 | $17,244 | $3,611 | 20.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 110 | 113 | $11,555 | $2,532 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $8,400 | $1,723 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,559 | $1,674 | 19.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 161 | 185 | $4,255 | $1,554 | 36.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 107 | 110 | $5,092 | $1,086 | 21.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $960.00 | $732.48 | 76.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 144 | 150 | $1,500 | $511.50 | 34.1% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 23 | 23 | $1,564 | $358.80 | 22.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $360.00 | $352.80 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 213 | $82,560 | $18,443 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 118 | 118 | $39,648 | $15,368 | 38.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 20 | 151 | $18,422 | $6,990 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 53 | $14,628 | $3,225 | 22.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 115 | 117 | $11,583 | $2,688 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,577 | $1,457 | 26.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $5,795 | $1,330 | 22.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 105 | 106 | $6,148 | $1,037 | 16.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,400 | $1,029 | 73.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $5,250 | $1,028 | 19.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 36 | 36 | $2,448 | $565.12 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 145 | 176 | $4,048 | $520.77 | 12.9% |
About Dr. Thomas Weeks, MD
Dr. Thomas Weeks, MD is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679587257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Weeks, MD has received a total of $5,457 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 335 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,457).
As a Medicare-enrolled provider, Weeks has provided services to 4,102 Medicare beneficiaries, totaling 5,082 services with total Medicare billing of $216,752. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Atlanta, GA
- Active Since 07/28/2006
- Last Updated 06/07/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679587257
Products in Payments
- Ozempic (Drug) $438.42
- EVENITY (Biological) $270.08
- FARXIGA (Drug) $244.96
- UBRELVY (Drug) $230.38
- LEQVIO (Drug) $228.83
- Synthroid (Drug) $197.39
- MOUNJARO (Drug) $152.94
- Prolia (Biological) $148.30
- QULIPTA (Drug) $145.29
- Androgel (Drug) $143.82
- VRAYLAR (Drug) $142.64
- Vascepa (Drug) $137.94
- NURTEC ODT (Drug) $122.84
- ENTRESTO (Drug) $122.29
- REXULTI (Drug) $119.62
- Dexcom G6 Transmitter (Medical Supply) $117.27
- Repatha (Biological) $100.85
- LINZESS (Drug) $91.66
- Livalo (Drug) $71.99
- Kerendia (Drug) $69.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Tracey Henry
Internal Medicine — Payments: $304,663
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Mr. Robert Springer, M.d, M.D
Internal Medicine — Payments: $243,195